Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
About This Webinar

Sponsors must be able to balance the need for efficiency and inclusivity on the path to seeking drug approval for rare cancer. Focusing on this topic, our oncology experts will share valuable insights and strategies for developing and operationalizing clinical trials in this space in this free educational webinar.

Agenda
  • Defining what rare cancer means
  • Considerations for protocol design- including patient-reported outcomes (PRO)
  • Evolving approaches to feasibility
  • Strategies for operational delivery
  • Q&A with our experts
Language: English
Who can attend? Anyone with the event link can attend
Featured Presenters
Webinar hosting presenter
Senior Vice President, Oncology Strategy & Innovation, Ergomed
Debra Kientop is an experienced, strategic leader in oncology clinical development across Pharma, Biotech, and CRO industries. She has focus on patient-centricity and incorporating innovative solutions into clinical delivery. Her role is strategic and executive oversight of clinical trials, sponsor and KOL engagement.
Webinar hosting presenter
Senior Vice President, Global Medical Affairs, Ergomed
Dr. Marie-Edith A. Bonneterre, is based in Lille, France, and is board-certified in Medical Oncology. Her experience in both the hospital setting and the pharma industry, biotechnology and CRO arenas is focused on clinical development and innovative strategies. Her role is strategic and medical oversight of clinical trials, innovative development strategies.
Webinar hosting presenter
Founded in 1997, Ergomed is a global provider of high-quality services to the biopharmaceutical industry, spanning all phases of clinical trials, post-approval pharmacovigilance, and medical information. Ergomed Clinical Research is a complete, global Phase I-IV clinical development and trial management service with a strong heritage in the development of drugs in rare diseases and oncology.
Hosted By
BioAlliance Video Network webinar platform hosts                                       Rare Cancers: Recommendations for Oncology Clinical Development
BioAlliance Video Network's Webinars and Video Conferences